These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
348 related articles for article (PubMed ID: 21483489)
1. Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors. Peng L; Tepp WH; Johnson EA; Dong M PLoS Pathog; 2011 Mar; 7(3):e1002008. PubMed ID: 21483489 [TBL] [Abstract][Full Text] [Related]
2. Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons. Dong M; Liu H; Tepp WH; Johnson EA; Janz R; Chapman ER Mol Biol Cell; 2008 Dec; 19(12):5226-37. PubMed ID: 18815274 [TBL] [Abstract][Full Text] [Related]
3. Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation-dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor. Rummel A; Häfner K; Mahrhold S; Darashchonak N; Holt M; Jahn R; Beermann S; Karnath T; Bigalke H; Binz T J Neurochem; 2009 Sep; 110(6):1942-54. PubMed ID: 19650874 [TBL] [Abstract][Full Text] [Related]
4. Double receptor anchorage of botulinum neurotoxins accounts for their exquisite neurospecificity. Rummel A Curr Top Microbiol Immunol; 2013; 364():61-90. PubMed ID: 23239349 [TBL] [Abstract][Full Text] [Related]
5. Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F. Fu Z; Chen C; Barbieri JT; Kim JJ; Baldwin MR Biochemistry; 2009 Jun; 48(24):5631-41. PubMed ID: 19476346 [TBL] [Abstract][Full Text] [Related]
6. SV2 is the protein receptor for botulinum neurotoxin A. Dong M; Yeh F; Tepp WH; Dean C; Johnson EA; Janz R; Chapman ER Science; 2006 Apr; 312(5773):592-6. PubMed ID: 16543415 [TBL] [Abstract][Full Text] [Related]
7. Presynaptic targeting of botulinum neurotoxin type A requires a tripartite PSG-Syt1-SV2 plasma membrane nanocluster for synaptic vesicle entry. Joensuu M; Syed P; Saber SH; Lanoue V; Wallis TP; Rae J; Blum A; Gormal RS; Small C; Sanders S; Jiang A; Mahrhold S; Krez N; Cousin MA; Cooper-White R; Cooper-White JJ; Collins BM; Parton RG; Balistreri G; Rummel A; Meunier FA EMBO J; 2023 Jul; 42(13):e112095. PubMed ID: 37226896 [TBL] [Abstract][Full Text] [Related]
8. Tetanus toxin and botulinum toxin a utilize unique mechanisms to enter neurons of the central nervous system. Blum FC; Chen C; Kroken AR; Barbieri JT Infect Immun; 2012 May; 80(5):1662-9. PubMed ID: 22392932 [TBL] [Abstract][Full Text] [Related]
9. Identification of the SV2 protein receptor-binding site of botulinum neurotoxin type E. Mahrhold S; Strotmeier J; Garcia-Rodriguez C; Lou J; Marks JD; Rummel A; Binz T Biochem J; 2013 Jul; 453(1):37-47. PubMed ID: 23621114 [TBL] [Abstract][Full Text] [Related]
10. Association of botulinum neurotoxins with synaptic vesicle protein complexes. Baldwin MR; Barbieri JT Toxicon; 2009 Oct; 54(5):570-4. PubMed ID: 19362106 [TBL] [Abstract][Full Text] [Related]
11. Botulinum neurotoxin D-C uses synaptotagmin I and II as receptors, and human synaptotagmin II is not an effective receptor for type B, D-C and G toxins. Peng L; Berntsson RP; Tepp WH; Pitkin RM; Johnson EA; Stenmark P; Dong M J Cell Sci; 2012 Jul; 125(Pt 13):3233-42. PubMed ID: 22454523 [TBL] [Abstract][Full Text] [Related]
12. Association of botulinum neurotoxin serotypes a and B with synaptic vesicle protein complexes. Baldwin MR; Barbieri JT Biochemistry; 2007 Mar; 46(11):3200-10. PubMed ID: 17311420 [TBL] [Abstract][Full Text] [Related]
13. Novel ganglioside-mediated entry of botulinum neurotoxin serotype D into neurons. Kroken AR; Karalewitz AP; Fu Z; Kim JJ; Barbieri JT J Biol Chem; 2011 Jul; 286(30):26828-37. PubMed ID: 21632541 [TBL] [Abstract][Full Text] [Related]
14. Botulinum neurotoxin serotype C associates with dual ganglioside receptors to facilitate cell entry. Karalewitz AP; Fu Z; Baldwin MR; Kim JJ; Barbieri JT J Biol Chem; 2012 Nov; 287(48):40806-16. PubMed ID: 23027864 [TBL] [Abstract][Full Text] [Related]
15. Botulinum Neurotoxin Serotype A Recognizes Its Protein Receptor SV2 by a Different Mechanism than Botulinum Neurotoxin B Synaptotagmin. Weisemann J; Stern D; Mahrhold S; Dorner BG; Rummel A Toxins (Basel); 2016 May; 8(5):. PubMed ID: 27196927 [TBL] [Abstract][Full Text] [Related]
16. Mechanism of botulinum neurotoxin B and G entry into hippocampal neurons. Dong M; Tepp WH; Liu H; Johnson EA; Chapman ER J Cell Biol; 2007 Dec; 179(7):1511-22. PubMed ID: 18158333 [TBL] [Abstract][Full Text] [Related]
17. Synaptotagmins I and II act as nerve cell receptors for botulinum neurotoxin G. Rummel A; Karnath T; Henke T; Bigalke H; Binz T J Biol Chem; 2004 Jul; 279(29):30865-70. PubMed ID: 15123599 [TBL] [Abstract][Full Text] [Related]
18. Botulinum neurotoxin serotype D attacks neurons via two carbohydrate-binding sites in a ganglioside-dependent manner. Strotmeier J; Lee K; Völker AK; Mahrhold S; Zong Y; Zeiser J; Zhou J; Pich A; Bigalke H; Binz T; Rummel A; Jin R Biochem J; 2010 Oct; 431(2):207-16. PubMed ID: 20704566 [TBL] [Abstract][Full Text] [Related]
19. Structural basis for recognition of synaptic vesicle protein 2C by botulinum neurotoxin A. Benoit RM; Frey D; Hilbert M; Kevenaar JT; Wieser MM; Stirnimann CU; McMillan D; Ceska T; Lebon F; Jaussi R; Steinmetz MO; Schertler GF; Hoogenraad CC; Capitani G; Kammerer RA Nature; 2014 Jan; 505(7481):108-11. PubMed ID: 24240280 [TBL] [Abstract][Full Text] [Related]
20. Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells. Dong M; Richards DA; Goodnough MC; Tepp WH; Johnson EA; Chapman ER J Cell Biol; 2003 Sep; 162(7):1293-303. PubMed ID: 14504267 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]